PT - JOURNAL ARTICLE AU - TOMOKO TANAKA AU - MITSUGU FUJITA AU - HIROSHI HASEGAWA AU - AKIRA ARIMOTO AU - MASAYASU NISHI AU - EIJI FUKUOKA AU - YUTAKA SUGITA AU - TAKERU MATSUDA AU - YASUO SUMI AU - SATOSHI SUZUKI AU - YOSHIHIRO KAKEJI AU - KIMIHIRO YAMASHITA TI - Frequency of Myeloid-derived Suppressor Cells in the Peripheral Blood Reflects the Status of Tumor Recurrence DP - 2017 Jul 01 TA - Anticancer Research PG - 3863--3869 VI - 37 IP - 7 4099 - http://ar.iiarjournals.org/content/37/7/3863.short 4100 - http://ar.iiarjournals.org/content/37/7/3863.full SO - Anticancer Res2017 Jul 01; 37 AB - Background: Malignant tumors inhibit antitumor immune responses, which are driven by T-regulatory cells or myeloid-derived suppressor cells (MDSCs). Since MDSCs are involved in invasion, migration, and metastasis of tumor cells, we hypothesized that MDSCs are also involved in tumor recurrence after surgical resection. Materials and Methods: C57BL/6 mice were subcutaneously inoculated with B16F10 melanoma cells in the right flank. In some experiments, established tumors were surgically resected. Peripheral blood was drawn over time, and immune cells and cytokines were evaluated using flow cytometry. Results: MDSCs and relevant pro-inflammatory cytokines increased in the peripheral blood of tumor-bearing mice. Moreover, the frequency of MDSCs rapidly increased in mice with tumor recurrence. Conclusion: The frequency of MDSCs in the peripheral blood of tumor-bearing mice reflects the status of tumor progression as well as tumor recurrence. Continuous monitoring of MDSCs in the peripheral blood might be a useful indicator of tumor recurrence.